0001388658-20-000280.txt : 20201203 0001388658-20-000280.hdr.sgml : 20201203 20201203180337 ACCESSION NUMBER: 0001388658-20-000280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201201 FILED AS OF DATE: 20201203 DATE AS OF CHANGE: 20201203 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vort David A CENTRAL INDEX KEY: 0001670676 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37918 FILM NUMBER: 201367962 MAIL ADDRESS: STREET 1: C/O IRHYTHM TECHNOLOGIES, INC. STREET 2: 650 TOWNSEND STREET, SUITE 380 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iRhythm Technologies, Inc. CENTRAL INDEX KEY: 0001388658 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 208149544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 BUSINESS PHONE: 415-632-5700 MAIL ADDRESS: STREET 1: 650 TOWNSEND STREET STREET 2: SUITE 500 CITY: San Francisco STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies, Inc. DATE OF NAME CHANGE: 20110429 FORMER COMPANY: FORMER CONFORMED NAME: IRhythm Technologies Inc DATE OF NAME CHANGE: 20070201 4 1 wf-form4_160703660430501.xml FORM 4 X0306 4 2020-12-01 0 0001388658 iRhythm Technologies, Inc. IRTC 0001670676 Vort David A C/O IRHYTHM TECHNOLOGIES, INC. 699 8TH ST #600 SAN FRANCISCO CA 94103 0 1 0 0 EVP, Sales Common Stock 2020-12-01 4 M 0 5000 17 A 20602 D Common Stock 2020-12-01 4 S 0 596 239.7056 D 20006 D Common Stock 2020-12-01 4 S 0 1275 241.0109 D 18731 D Common Stock 2020-12-01 4 S 0 1724 242.1337 D 17007 D Common Stock 2020-12-01 4 S 0 350 242.89 D 16657 D Common Stock 2020-12-01 4 S 0 1055 243.9711 D 15602 D Employee Stock Option (right to buy) 17.0 2020-12-01 4 M 0 5000 0 D 2020-09-21 2026-10-20 Common Stock 5000.0 7777 D The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020. Includes 23 shares acquired pursuant to the issuer's 2016 Employee Stock Purchase Plan on November 30, 2020. This transaction was executed in multiple trades at prices ranging from $239.295 to $240.12 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $240.465 to $241.43 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $241.62 to $242.59 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $242.65 to $242.93 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This transaction was executed in multiple trades at prices ranging from $243.715 to $244.51 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. This option is fully vested and exercisable in full. /s/ Christina Delfin, attorney in fact 2020-12-03